[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366427-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366427-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prognostic-value-of-lncrna-dlgap1-as2-in-bladder-cancer-and-its-regulatory-effect-on-tumor-progression","Prognostic value of LncRNA DLGAP1-AS2 in bladder cancer - and its regulatory effect on tumor progression","","Research investigates the clinical significance and mechanisms of DLGAP1-AS2 in bladder cancer (BLCA). Cancerous and normal tissues from 86 BLCA patients were analyzed using qPCR for DLGAP1-AS2 and miR-451a. Associations with smoking history, clinical parameters, and prognosis were assessed by chi-square, Cox model, and Kaplan-Meier analyses. DLGAP1-AS2, alone or with miR-451a, was silenced in BLCA cell lines; proliferation, migration, and invasion were measured with CCK-8 and Transwell assays.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prognostic-value-of-lncrna-dlgap1-as2-in-bladder-cancer-and-its-regulatory-effect-on-tumor-progression/366427/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prognostic-value-of-lncrna-dlgap1-as2-in-bladder-cancer-and-its-regulatory-effect-on-tumor-progression/366427.png","ImageObject",300,407,{"name":42,"@type":43},"Mabel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of examining DLGAP1-AS2 in bladder cancer?","Question",{"text":63,"@type":64},"The study evaluates DLGAP1-AS2’s clinical significance and its potential mechanisms for regulating BLCA cell behavior and tumor progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was DLGAP1-AS2 expression measured and related to patient outcomes?",{"text":68,"@type":64},"qPCR measured DLGAP1-AS2 in cancerous and normal tissues; chi-square, Cox modeling, and Kaplan-Meier analyses assessed correlations with clinical parameters and prognosis.",{"name":70,"@type":61,"acceptedAnswer":71},"What cellular effects occur when DLGAP1-AS2 is silenced, and how does miR-451a interact?",{"text":72,"@type":64},"DLGAP1-AS2 silencing reduces BLCA cell proliferation, migration, and invasion. miR-451a is down-regulated and shows a negative regulatory interaction with DLGAP1-AS2, and co-silencing restores cell behaviors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366427,1790207267,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","Zhao et al. Discover Oncology (2025) 16:1578 [https://doi.org/10.1007/s12672-025-03397-z](https://doi.org/10.1007/s12672-025-03397-z)  \nDiscover Oncology  \nRESEARCH Open Access  \nPrognostic value of LncRNA DLGAP1-AS2 in bladder cancer and its regulatory effect  \non tumor progression  \nYuhui Zhao 1†, Xiaotong Wu 1†, Yi Zheng2, Huiming Bai 1, Zhihang Zhang3, Mingzhi Li 1, Xiaofeng He 1* and Chao Yu 1*  \n†Yuhui Zhao and Xiaotong Wu have contributed equally to this work.  \n*Correspondence: Xiaofeng He [xiaobeiyfj3@163.com](xiaobeiyfj3@163.com)[ ](xiaobeiyfj3@163.com)Chao Yu  \n[chaoyudr1@163.com](chaoyudr1@163.com)[ ](chaoyudr1@163.com)1Department of Urology, Longhua Hospital Shanghai University of Traditional Chinese Medicine, No. 725, Wanping South Road, Shanghai 200032, China 2Department of Breast Surgery, Zhengzhou Traditional Chinese Medicine Hospital,  \nZhengzhou 452400, China 3Department of Urology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine),  \nHangzhou 310006, China  \nAbstract  \nBackground Bladder cancer (BLCA) represents one of the most prevalent malignant neoplasms within the urinary system, and its incidence is progressively rising annually in China.  \nObjectives This research investigated the clinical significance of DLGAP1-AS2, and examined its potential mechanisms in modulating the behavior of BLCA cells. Methods This study collected cancerous and normal tissue samples from 86 BLCA patients. qPCR was employed to assess DLGAP1-AS2 and miR-451a expression. Chisquare test was utilized to analyze the correlation between DLGAP1-AS2 and clinical parameters. Cox model and Kaplan-Meier analysis were conducted to evaluate the association between DLGAP1-AS2 and the prognosis of BLCA patients. Furthermore, DLGAP1-AS2 was silenced, both independently and jointly with miR-451a, in BLCA cell lines. CCK-8 assay assessed cell proliferation, and the Transwell assay evaluated cell migration and invasion capabilities.  \nResults DLGAP1-AS2 was elevated in BLCA tissues and exhibited a correlation with both smoking history and pathological features in BLCA patients. DLGAP1-AS2 was identified as a prognostic risk factor, wherein patients exhibiting low expression had a more favorable prognosis. DLGAP1-AS2 was up-regulated in BLCA cells, and its silencing led to a reduction in the proliferation, migration, and invasion of BLCA cells. Conversely, miR-451a was down-regulated in BLCA tissues and cells, and it demonstrated a negative regulatory interaction with DLGAP1-AS2 . The concurrent silencing of DLGAP1-AS2 and miR-451a effectively restored the biological behaviors of BLCA cells.  \nConclusion DLGAP1-AS2 is a potential biomarker for evaluating the severity of BLCA and for predicting clinical prognosis. DLGAP1-AS2 regulates the malignant progression of BLCA via miR-451a.  \nKeywords Bladder cancer, LncRNA, MiRNA, Prognosis, Cell behavior  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.","cbCaieBaNHsDkmxJ","https://ap.wps.com/l/cbCaieBaNHsDkmxJ","pdf",1978630,15,"English","# Abstract\n# Introduction","[{\"question\":\"What is the purpose of examining DLGAP1-AS2 in bladder cancer?\",\"answer\":\"The study evaluates DLGAP1-AS2’s clinical significance and its potential mechanisms for regulating BLCA cell behavior and tumor progression.\"},{\"question\":\"How was DLGAP1-AS2 expression measured and related to patient outcomes?\",\"answer\":\"qPCR measured DLGAP1-AS2 in cancerous and normal tissues; chi-square, Cox modeling, and Kaplan-Meier analyses assessed correlations with clinical parameters and prognosis.\"},{\"question\":\"What cellular effects occur when DLGAP1-AS2 is silenced, and how does miR-451a interact?\",\"answer\":\"DLGAP1-AS2 silencing reduces BLCA cell proliferation, migration, and invasion. miR-451a is down-regulated and shows a negative regulatory interaction with DLGAP1-AS2, and co-silencing restores cell behaviors.\"}]","Prognostic value of LncRNA DLGAP1-AS2 in bladder cancer - and its regulatory effect on tumor progression | PDF",1790165486,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4573fddd844832ef9ec74f1673b07b4.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0368ce623d9f3c0193c4f315b1a4bd9a.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e80228ccf0e7aacf42bbc81a07653c0.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fcdac4a20c53c35bbf55c912d6343d3.webp",980,1306]